Literature DB >> 15295691

Decreased HIV transmission after a policy of providing free access to highly active antiretroviral therapy in Taiwan.

Chi-Tai Fang1, Hsu-Mei Hsu, Shiing-Jer Twu, Mao-Yen Chen, Yu-Yin Chang, Jing-Shiang Hwang, Jung-Der Wang, Che-Yen Chuang.   

Abstract

BACKGROUND: Taiwan established a nationwide surveillance system for human immunodeficiency virus (HIV) infection in 1989 and adopted a policy to provide all HIV-infected citizens with free access to highly active antiretroviral therapy (HAART) beginning in April 1997. This provided an opportunity to determine the effect of the widespread use of HAART on the evolution of the HIV epidemic.
METHODS: We analyzed national HIV surveillance data. The HIV transmission rate was estimated by use of an exponential model of HIV epidemic evolution, with statistical projection over the interval between infection and detection to fit the surveillance data.
RESULTS: By the end of 2002, the cumulative number of HIV-infected citizens in Taiwan had reached 4390 (0.019% of the total population). After free access to HAART was established, the estimated HIV transmission rate decreased by 53% (0.391 vs. 0.184 new cases/prevalent case-year [95% confidence interval, 31%-65%]). There was no statistically significant change in the incidence of syphilis, in the general population or among HIV-positive patients, during the same period.
CONCLUSION: Providing free HAART to all HIV-infected citizens was associated with a 53% decrease in the HIV transmission rate and contributed to the control of the HIV epidemic in Taiwan.

Entities:  

Mesh:

Year:  2004        PMID: 15295691     DOI: 10.1086/422601

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  100 in total

1.  Antiretroviral therapy as HIV prevention: status and prospects.

Authors:  Kenneth H Mayer; Kartik K Venkatesh
Journal:  Am J Public Health       Date:  2010-08-19       Impact factor: 9.308

Review 2.  Does antiretroviral therapy prevent HIV transmission to sexual partners?

Authors:  Tahaniyat Lalani; Charles Hicks
Journal:  Curr HIV/AIDS Rep       Date:  2007-05       Impact factor: 5.071

Review 3.  Is expanded HIV treatment preventing new infections? Impact of antiretroviral therapy on sexual risk behaviors in the developing world.

Authors:  Kartik K Venkatesh; Timothy P Flanigan; Kenneth H Mayer
Journal:  AIDS       Date:  2011-10-23       Impact factor: 4.177

4.  The use of highly active retroviral therapy to reduce HIV incidence at the population level.

Authors:  Aranka Anema; Evan Wood; Julio S G Montaner
Journal:  CMAJ       Date:  2008-07-01       Impact factor: 8.262

5.  Does antiretroviral therapy prevent HIV transmission to sexual partners?

Authors:  Tahaniyat Lalani; Charles Hicks
Journal:  Curr Infect Dis Rep       Date:  2008-05       Impact factor: 3.725

Review 6.  Antiretroviral therapy: a key component of a comprehensive HIV prevention strategy.

Authors:  Mark W Hull; Julio Montaner
Journal:  Curr HIV/AIDS Rep       Date:  2011-06       Impact factor: 5.071

7.  High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa.

Authors:  Frank Tanser; Till Bärnighausen; Erofili Grapsa; Jaffer Zaidi; Marie-Louise Newell
Journal:  Science       Date:  2013-02-22       Impact factor: 47.728

Review 8.  Realizing the potential of treatment as prevention: global ART policy and treatment coverage.

Authors:  Somya Gupta; Brian Williams; Julio Montaner
Journal:  Curr HIV/AIDS Rep       Date:  2014-12       Impact factor: 5.071

9.  A Novel Integrated Cognitive-Behavioral Therapy for Anxiety and Medication Adherence Among Persons Living With HIV/AIDS.

Authors:  Charles P Brandt; Daniel J Paulus; Monica Garza; Chad Lemaire; Peter J Norton; Michael J Zvolensky
Journal:  Cogn Behav Pract       Date:  2017-03-02

Review 10.  Behavioral and biomedical combination strategies for HIV prevention.

Authors:  Linda-Gail Bekker; Chris Beyrer; Thomas C Quinn
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.